Pathophysiology of Childhood Hemolytic Uremic Syndrome
Pathophysiology of Childhood Hemolytic Uremic Syndrome
批准号:
6922877
负责人:
PHILLIP I TARR
金额:
$38.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-02-01 至 2008-06-30
关键词:
Escherichia coli infectionsbacterial cytopathogenic effectbeta globulinchild (0-11)comorbiditycomplementdisease /disorder modeldisease /disorder prevention /controldisease /disorder proneness /riskearly diagnosisfibringenetic polymorphismgenetic susceptibilityhemolytic anemiahost organism interactionhuman genetic material taghuman subjectmodel design /developmentmolecular pathologynucleic acid sequencepathologic processpatient oriented researchpediatricsrenal failurethrombosisvascular endothelium
中文摘要
性状(由申请方提供):大肠埃希菌O157:H7相关
溶血性尿毒综合征(HUS)仍然是一个具有挑战性的医学问题。
广泛的血栓形成,伴随纤维蛋白溶解抑制,
肾损伤的最早迹象。此外,血栓形成趋势
预测随后发生的溶血尿毒综合征的严重程度。很可能是严重的内皮损伤
在肾损伤导致溶血尿毒综合征之前这种损伤是可以研究的,而且,
可能是为了减轻其影响。
在这项资助中,将研究受感染儿童的血栓形成过程
强烈地。具体来说,我们将检验血栓形成
明确先于肾损伤,并且最初的纤维蛋白形成率
评价E.大肠杆菌O157:H7感染与预后相关(目的1)。到
为了进一步评估凝血损伤,我们还将检验以下假设:
第一天和第二天之间的纤维蛋白净间隔积累
观察预测了这种感染的结果,
在血栓形成前动力学基础的病理生理级联反应,导致
HUS的发展(目标2)。
我们还将使用我们独特的人口来检验假设,即(a)
补体系统的激活程度可预测儿童
e.大肠杆菌O157:H7感染,和(B)一种或多种因子H基因多态性,
与此相关的结果(目标3)。最后,由于内皮细胞
可能是关键的进化HUS,我们将测试的假设,
循环内皮细胞浓度之间的差异,
受感染的儿童预测结果。我们还将检验辅助假设
这些细胞表达与其原位损伤相关的蛋白质,
激活(目标4)。
一个独特的网络已经组装,以确定儿童的风险发展
HUS平均在HUS发展前三天。这是一个不充分的
研究,但绝对合适的模型,毒素相关的HUS。这个网络
将与混凝领域的调查专业知识相结合
评估、补体病理生理学和遗传学以及内皮细胞
生物学该项目旨在更全面地了解级联领导
到HUS,并与此知识,成功地阻断这一进程。
英文摘要
DESCRIPTION (provided by applicant): Escherichia coli O157:H7-associated
hemolytic uremic syndrome (HUS) remains a challenging medical problem.
Extensive thrombogenesis, with accompanying fibrinolysis inhibition, precede
the earliest indications of renal injury. Trends in thrombogenesis moreover
predict the severity of ensuing HUS. Presumably, a massive endothelial injury
before renal injury leads to HUS. This injury is amenable to study, and,
possibly, to the attenuation of its effects.
In this grant, the thrombogenic process in infected children will be studied
intensively. Specifically, we will test the hypotheses that thrombogenesis
clearly precedes renal injury, and that the rate of fibrin formation on initial
assessment of E. coli O157:H7 infections is associated with outcome (Aim 1). To
further assess the coagulation lesion, we will also test the hypotheses that
net interval accumulation of fibrin between the first and second day of
observation predicts outcome of this infection, and that time-dependent changes
in prothrombotic kinetics underlie the pathophysiologic cascade leading to the
development of HUS (Aim 2).
We will also use our unique population to test the hypotheses that (a) the
degree of activation of the complement system predicts outcome in children with
E. coli O157:H7 infection, and (b) one or more factor H gene polymorphisms is
associated with this outcome (Aim 3). Finally, because the endothelial cell is
likely to be critical in the evolution of HUS, we will test the hypothesis that
differences between the concentration of circulating endothelial cells in
infected children predict outcome. We shall also test the subsidiary hypothesis
that these cells express proteins plausibly related to their in situ injury or
activation (Aim 4).
A unique network has been assembled to identify children at risk of developing
HUS an average of three days before HUS develops. This is an inadequately
studied, but absolutely appropriate, model for toxin-related HUS. This network
will be amalgamated with investigative expertise in the fields of coagulation
assessment, complement pathophysiology and genetics, and endothelial cell
biology. The project seeks a more complete understanding of the cascade leading
to HUS, and, with this knowledge, the successful interdiction of this process.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Escherichia coli O157 exposure in Wyoming and Seattle: serologic evidence of rural risk.
怀俄明州和西雅图的大肠杆菌 O157 暴露:农村风险的血清学证据。
DOI:
10.3201/eid0910.020254
发表时间:
2003
期刊:
Emerging infectious diseases
影响因子:
11.8
作者:
[Haack,JasonP, Jelacic,Srdjan, Besser,ThomasE, Weinberger,Edward, Kirk,DonaldJ, McKee,GarryL, Harrison,ShannonM, Musgrave,KarlJ, Miller,Gayle, Price,ThomasH, Tarr,PhilipI]
通讯作者:
Tarr,PhilipI
Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures.
粪便和肉汤培养物中大肠杆菌 O157:H7 抗原检测与山梨糖醇-麦康凯琼脂粪便培养物中大肠杆菌 O157:H7 抗原检测的比较。
DOI:
10.1128/jcm.38.9.3404-3406.2000
发表时间:
2000
期刊:
Journal of clinical microbiology
影响因子:
9.4
作者:
[Stapp,JR, Jelacic,S, Yea,YL, Klein,EJ, Fischer,M, Clausen,CR, Qin,X, Swerdlow,DL, Tarr,PI]
通讯作者:
Tarr,PI
Thrombogenic alleles, Escherichia coli O157:H7 infections, and hemolytic uremic syndrome.
血栓形成等位基因、大肠杆菌 O157:H7 感染和溶血性尿毒症综合征。
DOI:
10.1097/00001721-200106000-00009
发表时间:
2001
期刊:
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
影响因子:
--
作者:
[Sprouse,JT, Wong,CS, Chandler,WL, Williams,GD, Watkins,SL, Tarr,PI]
通讯作者:
Tarr,PI
Platelet-activating factor and Escherichia coliO157:H7 infections.
血小板激活因子和大肠杆菌O157:H7 感染。
DOI:
10.1007/s00467-002-0970-7
发表时间:
2002
期刊:
Pediatric nephrology (Berlin, Germany)
影响因子:
--
作者:
[Smith,JodiM, Jones,Falaah, Ciol,MarciaA, Jelacic,Srdjan, Boster,DanielR, Watkins,SandraL, Williams,GlynD, Tarr,PhillipI, HendersonJr,WilliamR]
通讯作者:
HendersonJr,WilliamR
The Neonatal Microbiome and Necrotizing Enterocolitis
-
批准号:8134250
-
项目类别:
-
资助金额:$262.18万
-
财政年份:2009
-
负责人:PHILLIP I TARR
-
依托单位:
The Neonatal Microbiome and Necrotizing Enterocolitis
-
批准号:8318269
-
项目类别:
-
资助金额:$248.1万
-
财政年份:2009
-
负责人:PHILLIP I TARR
-
依托单位:
The Neonatal Microbiome and Necrotizing Enterocolitis
-
批准号:7650793
-
项目类别:
-
资助金额:$102.5万
-
财政年份:2009
-
负责人:PHILLIP I TARR
-
依托单位:
The Neonatal Microbiome and Necrotizing Enterocolitis
-
批准号:8111454
-
项目类别:
-
资助金额:$250.0万
-
财政年份:2009
-
负责人:PHILLIP I TARR
-
依托单位:
STRATEGIC TARGETING OF VIRAL GENOMES IN BILIARY ATRESIA
-
批准号:7599257
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2008
-
负责人:PHILLIP I TARR
-
依托单位:
THE GUT MICROBIOME IN DEVELOPMENT, HEALTH, AND DISEASE
-
批准号:7614942
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2008
-
负责人:PHILLIP I TARR
-
依托单位:
Nucleotide Polymorphisms in Enteric Pathogens
-
批准号:7252325
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2006
-
负责人:PHILLIP I TARR
-
依托单位:
Pathophysiology of Hemolytic Uremic Syndrome
-
批准号:6974595
-
项目类别:
-
资助金额:$1.39万
-
财政年份:2004
-
负责人:PHILLIP I TARR
-
依托单位:
Pathophysiology of Childhood Hemolytic Uremic Syndrome
-
批准号:6972016
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2004
-
负责人:PHILLIP I TARR
-
依托单位:
Pathophysiology of Childhood Hemolytic Uremic Syndrome
-
批准号:6613831
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2003
-
负责人:PHILLIP I TARR
-
依托单位:
Pathophysiology of Childhood Hemolytic Uremic Syndrome
-
批准号:6755549
-
项目类别:
-
资助金额:$36.33万
-
财政年份:2003
-
负责人:PHILLIP I TARR
-
依托单位:
Pathophysiology of Childhood Hemolytic Uremic Syndrome
-
批准号:6789956
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2003
-
负责人:PHILLIP I TARR
-
依托单位:
EVOLUTION OF VIRULENCE BY GENE ACQUISITION
-
批准号:6053534
-
项目类别:
-
资助金额:$42.86万
-
财政年份:1999
-
负责人:PHILLIP I TARR
-
依托单位:
EVOLUTION OF VIRULENCE BY GENE ACQUISITION
-
批准号:6534253
-
项目类别:
-
资助金额:$9.84万
-
财政年份:1999
-
负责人:PHILLIP I TARR
-
依托单位:
EVOLUTION OF VIRULENCE BY GENE ACQUISITION
-
批准号:6744221
-
项目类别:
-
资助金额:$23.9万
-
财政年份:1999
-
负责人:PHILLIP I TARR
-
依托单位:
EVOLUTION OF VIRULENCE BY GENE ACQUISITION
-
批准号:6171206
-
项目类别:
-
资助金额:$42.21万
-
财政年份:1999
-
负责人:PHILLIP I TARR
-
依托单位:
EVOLUTION OF VIRULENCE BY GENE ACQUISITION
-
批准号:6374501
-
项目类别:
-
资助金额:$35.09万
-
财政年份:1999
-
负责人:PHILLIP I TARR
-
依托单位:
PATHOPHYSIOLOGY OF CHILDHOOD HEMOLYTIC UREMIC SYNDROME
-
批准号:2017624
-
项目类别:
-
资助金额:$15.8万
-
财政年份:1996
-
负责人:PHILLIP I TARR
-
依托单位:
ESCHERICHIA COLI 0157--H7 ADHERENCE AND COLONIZATION
-
批准号:2075462
-
项目类别:
-
资助金额:$17.56万
-
财政年份:1996
-
负责人:PHILLIP I TARR
-
依托单位:
Pathophysiology of Childhood Hemolytic Uremic Syndrome
-
批准号:6400742
-
项目类别:
-
资助金额:$44.88万
-
财政年份:1996
-
负责人:PHILLIP I TARR
-
依托单位: